Page last updated: 2024-10-27

flecainide and Dizzyness

flecainide has been researched along with Dizzyness in 7 studies

Flecainide: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
flecainide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid with the primary amino group of piperidin-2-ylmethylamine. An antiarrhythmic agent used (in the form of its acetate salt) to prevent and treat tachyarrhythmia (abnormal fast rhythm of the heart).

Research Excerpts

ExcerptRelevanceReference
"Flecainide is an oral class IC antiarrhythmic drug whose most common extracardiac adverse reactions are "dizziness" and "visual disturbances."9.22A Possible Mechanism for Flecainide Induced Dizziness. ( Garaycochea, O; Manrique-Huarte, R; Pérez-Fernández, N; Riesgo, Á, 2022)
"During a one-week short-term in-hospital period, 60 patients with chronic ventricular arrhythmias were treated with 200 mg flecainide twice a day."7.67Flecainide: one-year efficacy in patients with chronic ventricular arrhythmias. ( Balakumaran, K; Hagemeijer, F; Hugenholtz, PG; Jovanovic, A; Lubsen, J; Polak, BC; Roelandt, J; ten Cate, FJ; Vanhaleweyk, G; Withagen, A, 1984)
"Flecainide is an oral class IC antiarrhythmic drug whose most common extracardiac adverse reactions are "dizziness" and "visual disturbances."5.22A Possible Mechanism for Flecainide Induced Dizziness. ( Garaycochea, O; Manrique-Huarte, R; Pérez-Fernández, N; Riesgo, Á, 2022)
"During a one-week short-term in-hospital period, 60 patients with chronic ventricular arrhythmias were treated with 200 mg flecainide twice a day."3.67Flecainide: one-year efficacy in patients with chronic ventricular arrhythmias. ( Balakumaran, K; Hagemeijer, F; Hugenholtz, PG; Jovanovic, A; Lubsen, J; Polak, BC; Roelandt, J; ten Cate, FJ; Vanhaleweyk, G; Withagen, A, 1984)
" The most frequently reported extracardiac adverse experiences were dizziness (30%) and visual disturbances (28%), often occurring in tandem."1.27Extracardiac adverse effects of flecainide. ( Gentzkow, GD; Sullivan, JY, 1984)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19904 (57.14)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (28.57)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Garaycochea, O1
Riesgo, Á1
Manrique-Huarte, R1
Pérez-Fernández, N1
Lip, GY1
Fauchier, L1
Freedman, SB1
Van Gelder, I1
Natale, A1
Gianni, C1
Nattel, S1
Potpara, T1
Rienstra, M1
Tse, HF1
Lane, DA1
Bonilla-Palomas, JL1
López-López, JM1
Moreno-Conde, M1
Gallego de la Sacristana, A1
Gámez-López, AL1
Villar-Ráez, A1
Conard, GJ1
Carlson, GL1
Frost, JW1
Ober, RE1
Leon, AS1
Hunninghake, DB1
Vanhaleweyk, G1
Balakumaran, K1
Lubsen, J1
ten Cate, FJ1
Jovanovic, A1
Hagemeijer, F1
Withagen, A1
Polak, BC1
Roelandt, J1
Hugenholtz, PG1
Gentzkow, GD1
Sullivan, JY1
Nestico, PF1
Morganroth, J1

Reviews

2 reviews available for flecainide and Dizzyness

ArticleYear
A Possible Mechanism for Flecainide Induced Dizziness.
    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2022, 06-01, Volume: 43, Issue:5

    Topics: Aged; Bilateral Vestibulopathy; Dizziness; Flecainide; Head Impulse Test; Humans; Male; Vertigo; Ves

2022
Atrial fibrillation.
    Nature reviews. Disease primers, 2016, 03-31, Volume: 2

    Topics: Ablation Techniques; Anticoagulants; Aspirin; Atrial Fibrillation; Dizziness; Dyspnea; Electric Coun

2016

Other Studies

5 other studies available for flecainide and Dizzyness

ArticleYear
Type I Brugada electrocardiogram pattern induced by metoclopramide.
    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2011, Volume: 13, Issue:9

    Topics: Brugada Syndrome; Dizziness; Dopamine Antagonists; Flecainide; Humans; Male; Metoclopramide; Middle

2011
Plasma concentrations of flecainide acetate, a new antiarrhythmic agent, in humans.
    Clinical therapeutics, 1984, Volume: 6, Issue:5

    Topics: Adult; Anti-Arrhythmia Agents; Chromatography, Gas; Dizziness; Drug Tolerance; Electrocardiography;

1984
Flecainide: one-year efficacy in patients with chronic ventricular arrhythmias.
    European heart journal, 1984, Volume: 5, Issue:10

    Topics: Adult; Aged; Arrhythmias, Cardiac; Chronic Disease; Dizziness; Drug Evaluation; Electrocardiography;

1984
Extracardiac adverse effects of flecainide.
    The American journal of cardiology, 1984, Feb-27, Volume: 53, Issue:5

    Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dizziness; Dyspnea; Flecainide; Headache; Humans; Naus

1984
Flecainide: a new antiarrhythmic agent.
    American family physician, 1986, Volume: 34, Issue:5

    Topics: Arrhythmias, Cardiac; Cardiac Complexes, Premature; Dizziness; Electrophysiology; Flecainide; Hemody

1986